BioCentury
ARTICLE | Company News

Array, Vertex in phosphatase drug deal

September 5, 2001 7:00 AM UTC

The companies will develop small molecules against two phosphatase targets. ARRY is responsible for lead generation and optimization, and will receive an upfront fee and research funding for three yea...